Best of AC17 Session - Ambulatory Care - On-Demand

    • List Price: $35.00
    • Member Price: $25.00

Matters Close to the Heart: Cardio-Oncology in Breast Cancer in 2017

Therapeutic advancements over recent decades have led to a growing number of breast cancer survivors. However, these successes have been overshadowed by the unintended, and often devastating, cardiac outcomes affecting survivors of breast cancer. Anthracyclines and trastuzumab represent the agents responsible for left ventricular dysfunction and heart failure. In general, healthcare providers are operating in a reactive rather than a proactive manner when monitoring for cardiotoxicity. Ideally, detecting cardiac damage before it results in decline in ejection fraction may lead to better cardiac outcomes. Emerging strategies in prevention and monitoring will be highlighted.

Content Area: Patient Management & Therapeutics


Implementation of Advanced Pharmacy Services into a Multiple Myeloma Ambulatory Clinic


Many barriers exist to providing comprehensive care to patients with multiple myeloma. With the approval of multiple new agents, therapeutic decision making and the regimens patients are required to adhere to have become increasingly complex. In this session, experiences with the incorporation of clinical pharmacists into direct patient care within an ambulatory multiple myeloma clinic will be shared. The role of pharmacy specialists regarding support for therapeutic recommendations and monitoring, therapy adherence, compliance with Risk Evaluation and Mitigation Strategies (REMS), supportive care considerations, and financial and case management will also be reviewed. Finally, the outcomes resulting from the implementation of this service will be discussed.


Content Area: Patient Management & Therapeutics


Product Details:

Session from HOPA 2017 Annual Conference

Matters Close to the Heart: Cardio-Oncology in Breast Cancer in 2017

Speaker: Sandra Cuellar, PharmD BCOP


Learning Objectives:

1.      Review the epidemiology of cardiotoxicity in breast cancer patients.

2.   &nb...

Show More
There are not any reviews for this product.
Contains 0 items
Subtotal: $0.00